会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES OF OLEOYLETHANOLAMIDE-LIKE COMPOUNDS AND MODULATORS OF PPARα
    • 化合物,组合物和治疗用途的乙酰氨基酚类化合物和PPARα的调节剂
    • WO2005002524A2
    • 2005-01-13
    • PCT/US2004/021394
    • 2004-07-01
    • THE REGENTS OF THE UNIVERSITY OF CALIFORNIAFU, JinGAETANI, SilvanaPIOMELLI, Daniele
    • FU, JinGAETANI, SilvanaPIOMELLI, Daniele
    • A61K
    • A61K31/20
    • The present invention provides compounds, compositions, and methods for the treatment of disorders and conditions mediated by PPARa. The invention relates to the surprising discovery that oleoylethanolamide (OEA) is an endogenous high affinity and selective ligand of PPARa. The compounds of the invention include, but are not limited to, specific PPARa agonists sharing the receptor binding properties of OEA and fatty acid alkanolamides and their homologs which also are PPARa agonists. Such OEA-like compounds include, but are not limited to, compounds of the following formula: in which n is from 0 to 5, the sum of a and b can be from 0 to 4; Z is a member selected from the group consisting of -C(O)N(Ro) ; (Ro)NC(O) ; OC(O) ; (O)CO ; O; NRo; and S; and wherein Ro and R2 are members independently selected from the group consisting of unsubstituted or unsubstituted alkyl, hydrogen, C1 -C6 alkyl, and lower (C1-C6) acyl, and wherein up to eight hydrogen atoms are optionally substituted by methyl or a double bond, and the bond between carbons c and d may be unsaturated or saturated, or a pharmaceutically acceptable salt thereof.
    • 本发明提供了用于治疗由PPARα介导的病症和病症的化合物,组合物和方法。 本发明涉及令​​人惊奇的发现,即油基乙醇酰胺(OEA)是PPARα的内源性高亲和力和选择性配体。 本发明的化合物包括但不限于分享了OEA和脂肪酸链烷醇酰胺及其同系物的受体结合性质的特异性PPARα激动剂,它们也是PPARα激动剂。 这种OEA类化合物包括但不限于下式的化合物:其中n为0至5,a和b的和可以为0至4; Z是选自-C(O)N(Ro); (Ro)NC(O); OC(O); (O)CO; O; NRO; 和S; 并且其中R a和R 2是独立地选自未取代或未取代的烷基,氢,C 1 -C 6烷基和低级(C 1 -C 6)酰基的成员,并且其中多达8个氢原子任选地被甲基或双 碳和c之间的键可以是不饱和的或饱和的,或其药学上可接受的盐。